Midas Letter Live- Strainprint CTO on Cannabis At Work Partnership
Strainprint’s CTO, David Berg, recently sat down with the Midas Letter Live to talk about our partnership with Cannabis At Work. About Midas Letter is the journal of “best-in-class” companies in all sectors. Publisher James West is a recognized authority on investing in the emerging company segment having been a regularly featured guest on Business […]
Understanding Flavonoids
Learn more about Flavonoids in the Strainprint Community The cannabis herb produces more than 400 chemical compounds—all of which manifest in different efficacy profiles depending on consumption avenue, including ingestion (edibles) and inhalation (smoke and vapor, each producing different molecular profiles). The most noted and understood of these molecules are cannabinoids and terpenes. Cannabidiol (CBD) […]
Strainprint Featured in The Growth Op – OPINION: Cannabis industry is no island; inclusiveness, respect and clear rules needed to prevent all forms of harassment
Recent concerns demonstrate need to build on the positive foundation that exists.
Understanding CBD
https://stage.strainprint.ca/community/understanding-cbd/ To read the full article, visit the Strainprint Community…
Understanding Terpenes — Nerolidol
To learn more about this anti-bacterial, anti-cancer, anti-fungal, and anti-inflammatory super terpene, head over to the Strainprint Community…
Stephanie Karasick Featured on the Business of Cannabis
Stephanie Karasick Featured on Business of Cannabis- talking Strainprint Community, expansion to new markets, and leading with kindness.
